[EN] MODULATORS OF HEDGEHOG (HH) SIGNALLING PATHWAY<br/>[FR] MODULATEURS DE LA VOIE DE SIGNALISATION HEDGEHOG (HH)
申请人:E THERAPEUTICS PLC
公开号:WO2018078360A1
公开(公告)日:2018-05-03
There are described compounds of formula (I): and there use as a medicament in the treatment of conditions involving abnormal activation and/or malfunction of the of the hedgehog pathway, such as cancer, fibrosis and chronic graft-versus-host disease (cGVHD).